[Feasibility and security of laparoscopic (± robotic) total hysterectomy in outpatient surgery: A French multicenter retrospective study].

Faisabilité et sécurité de l’hystérectomie totale par voie cœlioscopique (± robot assisté) en chirurgie ambulatoire : une étude rétrospective multicentrique française.

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
05 2022
Historique:
received: 08 10 2021
revised: 14 12 2021
accepted: 20 12 2021
pubmed: 4 1 2022
medline: 9 6 2022
entrez: 3 1 2022
Statut: ppublish

Résumé

To assess the feasibility and safety of total hysterectomy by laparoscopic approach (± robot assisted) in ambulatory. French three-center retrospective study including 165 patients who had laparoscopic (± robot assisted) total hysterectomy scheduled as outpatients from January 2016 to December 2020. Clinical and perioperative data were collected. Factors associated with outpatient failure and rehospitalization were evaluated. The outpatient success rate was 92.7%. Factors associated with outpatient failure were incision time>13:00, large volume of blood loss, intraoperative complications with Oslo score≥2, uterine weight≥250g, indication for benign pathology, and robot-assisted approach. Among patients managed as outpatients, 7.2% were rehospitalized at a mean of 10 days from surgery. The factors associated with rehospitalization were the use of an effective antiaggregant or anticoagulant treatment and the use of intraoperative adhesiolysis. Four patients (2.6%) underwent revision surgery. Minimally invasive hysterectomy can be performed as an outpatient procedure even in cases of malignant pathology. Age and body mass index are not associated with an increased risk of failure or re-hospitalization within one month.

Identifiants

pubmed: 34979303
pii: S2468-7189(21)00349-4
doi: 10.1016/j.gofs.2021.12.011
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

374-381

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Auteurs

L Benoit (L)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

R Delangle (R)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

N T Van (NT)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

V Villefranque (V)

Service de gynécologie obstétrique, Hôpital Simone-Veil, 95600 Eaubonne, France.

M Koskas (M)

Service de gynécologie obstétrique, Bichat, université de Paris, AP-HP, 75018 Paris, France.

J Belghiti (J)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

C Uzan (C)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Inserm UMR_S_938, Cancer Biology and Therapeutics, centre de recherche Saint-Antoine (CRSA), Sorbonne Université, 75012 Paris, France.

G Canlorbe (G)

Service de chirurgie et cancérologie gynécologique et mammaire, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Inserm UMR_S_938, Cancer Biology and Therapeutics, centre de recherche Saint-Antoine (CRSA), Sorbonne Université, 75012 Paris, France. Electronic address: geoffroy.canlorbe@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH